EU Finds No Increase In Cancer Risk From Diabetes Drugs
The European Medicines Agency said Friday that its research into diabetes drugs made by Merck & Co. Inc., AstraZeneca PLC and others does not show an increased risk of precancerous changes...To view the full article, register now.
Already a subscriber? Click here to view full article